| Spring 2001 |
- Monitoring Anti-HIV Medicines: What Is the FDA’s Role?
- Dual Protease Inhibitors Gain Ground
- HIV-Related Fatigue
- Botswana: Context of the Epidemic
|
| Winter 2001 |
- The Persistent Epidemic: HIV Among Men Who Have Sex with Men
- Anal Neoplasia: A Growing Concern
- HIV/AIDS Pricing Report: Setting Objectives: Is There a Political Will?
- Lessons Learned from Natural History Studies in Women
|
| Autumn 2000 |
- Sexually Transmitted Diseases and HIV-Related Risks
- Restoring Immunity in HIV Disease
- Approaches to Interrupting HAART for the Treatment of HIV Infection
- Human Rights and the AIDS Crisis: The Debate over Resources
|
| Summer 2000 |
- The Global HIV/AIDS Epidemic
- Feasible Microbicides Remain Elusive
- Issues in HIV Postexposure Prophylaxis
- The Wide-Ranging Effects of Nucleoside Analogs: A Look at Mitochondrial Toxicity
|
|
Spring 2000
|
- HIV Persists Despite HAART
- Adverse Effects Associated with Antiretroviral Therapy
- Structured Treatment Interruption: Future Protocol or Wishful Thinking?
- Special Report on HIV as the Cause of AIDS
|
|
Year-End 1999
|
- Antiretroviral Pharmacology: Issues and Management
- Natural History and Treatment of Hepatitis C
- Status Report on HIV Vaccine Development
- HIV/AIDS in Adolescence
- HIV Skin Complications in the Age of HAART
|
|
Summer 1999
|
- Jay A. Levy, MD: HIV/AIDS Research at the Millennium
- Sexual Transmission in the Era of New Treatments
- Genotypic and Phenotypic Resistance Testing
- Global Perspectives on Nutrition and HIV Infection: A Special Report
|
|
April 1999
|
- HAART Attack: Metabolic Disorders During Long-Term Antiretroviral Therapy
- Current Challenges to HIV Research
- Volunteering for Clinical Trials
|
|
January 1999
|
- The Challenge of Adherence to Highly Active Anti-Retroviral Therapy
- Body Fat Change: More than Lipodystrophy
- Opportunistic Infections: Is It Safe to Stop Prophylaxis?
- Highlights from Recent Conferences
|
|
October 1998
|
- Coverage of the 12th World AIDS Conference
- Protease-Sparing Combination Regimens
- Tuberculosis
|
|
July 1998
|
- Unusual Body Changes: A Possible Side Effect of Anti-HIV Treatment?
- Blood Cell Deficiencies
- Advertising for AIDS Drugs
- HIV and Children: the Nutrition Story
|
|
April 1998
|
- DNA and Other Technologies for HIV Vaccines
- Herbs for HIV
- Side Effects Associated with Anti-HIV Drugs
- You and Your Doctor: Ideas on Managing One of the Most Important Relationships in Your Life
|
|
Jan. 1998
|
- Adherence and the HIV Community
- Resistance to Antiretroviral Drugs
- Hepatitis
- AIDS-Related Lymphoma
- Complementary and Alternative Medicine
|
|
Sept. 1997
|
DMP-266 and Adefovir Dipivoxil
Protease Inhibitor Drug Interactions
Adherence
Progressive Multifocal Leuko-
encephalopathy
Chinese Medicine for HIV Positive Women
|
|
June 1997
|
New HIV Treatment Guidelines
Nausea/Diarrhea/Food Safety
Women and HIV Conference Highlights
|
|
March 1997
|
3-Drug Therapy Reduces AIDS Progression and Death
Chemokines and HIV
Psychiatric Aspects of HIV
Peripheral Neuropathy
Retroviruses Conference Highlights
|
|
Dec. 1996
|
1592 - Most Important AIDS Drug in the Pipeline
Mycobacterium avium Complex
AIDS Dementia Complex
Perinatal HIV Transmission
ICAAC Conference Highlights
|
|
Sept. 1996
|
Highlights from the International Conference on AIDS
Anabolic Steroids and HIV-Related Wasting
HIV Vaccines
Advocacy Issues: Viral Load Access/Medical Marijuana/HMO Patient Rights
Treating HIV During Pregnancy
|
|
June 1996
|
Viral Load Testing
Pneumonia
Non-Nucleoside Reverse Transcriptase Inhibitor Drugs
HIV/AIDS in Children
Cervical Intraepithelial Neoplasia
|